Neoadjuvant Adebrelimab and Chemotherapy in High-rish ER+/HER2- BC
Clinical trial NCT06500208 · RECRUITING
Trial details
- NCT number
- NCT06500208
- Sponsor
- Shanghai Jiao Tong University School of Medicine
- Status
- RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2024-11-01
- Primary completion
- 2025-12-31
- Enrollment
- 48
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.